Search

everythinglearnresearchcommunity

for

Search:↓

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Low-dose oral minoxidil can help increase hair growth in women with hair loss.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

Oral minoxidil helps treat hair loss and has reversible side effects.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Menopause affects hair and skin; more research needed for treatment.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Spironolactone is effective and safe for treating excessive facial hair in women.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Eating healthy, exercising, and certain nutrients like myoinositol and omega-3s can help manage PCOS symptoms.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Long pulsed Nd: YAG laser is safe and effective for long-term hair reduction in darker skin types.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

The document likely discusses how to tell the difference between excessive hair growth and the development of male characteristics in women.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

The conclusion is that certain traits, including perceived facial aging and BMI, are linked to perceived youthfulness differently in men and women.